AGF Management
CGON icon

AGF Management’s CG Oncology CGON Stock Holding History

AGF Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.35M Buy
+117,731
New +$8.65M 0.03% 220

Other funds holding CGON

Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Renaissance Capital
Renaissance Capital Stamford, Connecticut $145M AUM 53.16% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Sicart Associates
Sicart Associates New York $413M AUM 28.3% 1-Year Est. Return

AGF Management's CGON Position: Q3 2026 in Review

AGF Management opened a new position in CG Oncology (CGON) in Q3 2026: 117,731 shares worth $8.35M. The stake represents 0.03% of the portfolio and ranks #220 among its holdings.

49 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • AGF Management held 117,731 shares of CG Oncology worth $8.35M as of Q3 2026.
  • CG Oncology was a new AGF Management position in Q3 2026.
  • CG Oncology made up 0.03% of AGF Management's portfolio in Q3 2026, its #220 holding.
  • 49 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on AGF Management's 13F filing for Q3 2026, filed 3 Nov 2026.